IRB Approval

PROTOCOL APPROVAL WITH MODIFICATIONS
DATE:

24 Jul 2019

TO:

Dawnyea Jackson, PhD

PROTOCOL:

F.D.A. Center for Tobacco Products - 17441 - Nicotine Education Project,
Nicotine Education Project: Qualitative Study to Gain Insights from Adult
Current and Former Smokers to Educate the General Public about Changing
Nicotine Standards (Pro00037456)

APPROVAL DATE:

24 Jul 2019

EXPIRATION DATE:

24 Jul 2020
IRB APPROVED DOCUMENTATION:

Protocol Version:



Protocol (Not Dated)

Consent Form:



Informed Consent Form (Advarra IRB Approved Version 24 Jul 2019)

Other Material:



Check-In Survey (Submitted as: Appendix E2_Check-In Survey_Former
Smokers_Use Nicotine_7.22.19)
Check-In Survey (Submitted as: Appendix E1_Check-In Survey_Current
Smokers_7.22.19)
Check-In Survey (Submitted as: Appendix E3_Check-In Survey_Former
Smokers_Quit All Forms of Nicotine_7.22.19)
Nicotine Education Project – Moderator Guide (90 Min) [Not Dated]
Screener (Not Dated)
Participant Check Out Form (Not Dated)
Screener Contact Sheet (Not Dated)








The IRB approved the above referenced protocol and your site with the modifications listed below on 24 Jul
2019:


Modifications to the Informed Consent Form

The above referenced material is available on your Advarra CIRBI Platform under the “IRB Issued
Documents” tab.
If there are any changes to the IRB approved material, IRB approval will be needed prior to use. This includes
changes in relative size and type of font in the material to be viewed by potential subjects.

Page 1 of 2

If the study is expected to last beyond the approval period, you must request and receive re-approval prior to
the expiration date noted above. A report to the Board on the status of this study is due prior to the expiration
date or at the time the study closes, whichever is earlier. It is recommended that you submit status reports at
least 4 weeks prior to your expiration date to avoid any additional fees or lapses in approval.
Approved investigators and sites are required to submit to Advarra for review, and await a response prior to
implementing, any amendments or changes in the protocol; informed consents; advertisements or recruitment
materials ("study-related materials"); investigators; or sites (primary and additional).
Approved investigators and sites are required to notify Advarra of the following reportable events, including,
but not limited to: unanticipated problems involving risks to subjects or others; unanticipated adverse device
effects; protocol violations that may affect the subjects’ rights, safety, or well-being and/or the completeness,
accuracy and reliability of the study data; subject death; suspension of enrollment; or termination of the study.
Please review the IRB Handbook located in the “Reference Materials” section of Advarra CIRBI™ Platform
(www.cirbi.net). A copy of the most recent IRB roster is also available.
Thank you for selecting Advarra IRB to provide oversight for your research project.

Page 2 of 2

Molly Barry

IRB Message Re: F.D.A. Center for Tobacco Products - 17441 - Nicotine Education
Project
1 message
[email protected]
Thu, Jul 25, 2019 at 1:42 PM
Reply-To: [email protected]
To: [email protected], [email protected], [email protected], [email protected],
[email protected]

CIRBI Link:

Pro00037456

Submission:

F.D.A. Center for Tobacco Products - 17441 - Nicotine Education Project

Protocol Title:

Nicotine Education Project: Qualitative Study to Gain Insights from Adult Current and Former
Smokers to Educate the General Public about Changing Nicotine Standards

From:

Advarra IRB

Attachment(s): There are no items to display

The approval with modifications notice is the IRB's final approval. The revisions to the consent form(s)
have been incorporaed on your behalf and no further action on your part is required. Thanks
Kind Regards,
Amy Redmond
443-283-1622 / [email protected]
Please click on the CIRBI link Pro00037456 and use the Contact IRB to respond to the message.

This communication and its attachments contain information from Advarra, Inc. or one of its subsidiaries, and is intended
for the exclusive use of the recipient(s) named above. It may contain information that is confidential and/or legally
privileged. Any unauthorized use that may compromise that confidentiality via distribution or disclosure is prohibited.
Please notify the sender immediately if you receive this communication in error, and delete it from your computer system.
Usage of Advarra IRB email addresses for non-business related activities is strictly prohibited.

Template:PRO_A_Contact Client